Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery
Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery
BACKGROUND: Omega-3 fatty acids (n-3 FAs) may have beneficial clinical effects, and n-3 FA supplements may improve outcome after surgery.
METHODS: In a randomized double-blind placebo-controlled trial in single centre, patients referred for elective colorectal cancer surgery received either an n-3 FA-enriched oral nutritional supplement (ONS) (Supportan®, 200 ml twice daily) providing 2·0 g eicosapentaenoic acid (EPA) and 1·0 g docosahexaenoic acid (DHA) per day, or a standard isocaloric and isonitrogenous ONS, for 7 days before and 7 days after surgery. The primary endpoint was infectious and non-infectious complications within 30 days of surgery. Secondary endpoints were length of hospital stay, intensive care unit admission, readmissions, and concentrations of marine n-3 FAs and arachidonic acid in granulocyte membranes.
RESULTS: Some 148 consecutive patients (68 women, 80 men; mean age 71 (range 41-89) years) were randomized. There was no significant difference between groups in infectious or non-infectious postoperative complications (P = 1·000). Granulocyte levels of EPA, DHA and docosapentaenoic acid (DPA) were significantly higher in the n-3 FA-enriched supplement group compared with the control group (P < 0·001). The arachidonic acid level in granulocytes was significantly lower in the enriched group than in the control group (P < 0·001).
CONCLUSION: EPA, DHA and DPA were incorporated into granulocytes in patients receiving n-3 FAs, but this was not associated with improved postoperative outcomes.
33-42
Sorensen, L.S.
19ec5f08-4030-481a-9720-b463b492c739
Thorlacius-Ussing, O.
01324bcb-7710-4b1d-bdd6-11691df706ba
Schmidt, E.B.
4874f79f-b771-46da-917a-8d8a8c912176
Rasmussen, H.H.
ce22c561-0d29-469e-86d4-0b5997eae4d6
Lundbye-Christensen, S.
57f72bf2-faf8-4892-95ed-f7d18d67330f
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Lindorff-Larsen, K.
5d244713-731d-4bd7-8860-5006a71d5464
January 2014
Sorensen, L.S.
19ec5f08-4030-481a-9720-b463b492c739
Thorlacius-Ussing, O.
01324bcb-7710-4b1d-bdd6-11691df706ba
Schmidt, E.B.
4874f79f-b771-46da-917a-8d8a8c912176
Rasmussen, H.H.
ce22c561-0d29-469e-86d4-0b5997eae4d6
Lundbye-Christensen, S.
57f72bf2-faf8-4892-95ed-f7d18d67330f
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Lindorff-Larsen, K.
5d244713-731d-4bd7-8860-5006a71d5464
Sorensen, L.S., Thorlacius-Ussing, O., Schmidt, E.B., Rasmussen, H.H., Lundbye-Christensen, S., Calder, P.C. and Lindorff-Larsen, K.
(2014)
Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery.
British Journal of Surgery, 101 (2), .
(doi:10.1002/bjs.9361).
(PMID:24281905)
Abstract
BACKGROUND: Omega-3 fatty acids (n-3 FAs) may have beneficial clinical effects, and n-3 FA supplements may improve outcome after surgery.
METHODS: In a randomized double-blind placebo-controlled trial in single centre, patients referred for elective colorectal cancer surgery received either an n-3 FA-enriched oral nutritional supplement (ONS) (Supportan®, 200 ml twice daily) providing 2·0 g eicosapentaenoic acid (EPA) and 1·0 g docosahexaenoic acid (DHA) per day, or a standard isocaloric and isonitrogenous ONS, for 7 days before and 7 days after surgery. The primary endpoint was infectious and non-infectious complications within 30 days of surgery. Secondary endpoints were length of hospital stay, intensive care unit admission, readmissions, and concentrations of marine n-3 FAs and arachidonic acid in granulocyte membranes.
RESULTS: Some 148 consecutive patients (68 women, 80 men; mean age 71 (range 41-89) years) were randomized. There was no significant difference between groups in infectious or non-infectious postoperative complications (P = 1·000). Granulocyte levels of EPA, DHA and docosapentaenoic acid (DPA) were significantly higher in the n-3 FA-enriched supplement group compared with the control group (P < 0·001). The arachidonic acid level in granulocytes was significantly lower in the enriched group than in the control group (P < 0·001).
CONCLUSION: EPA, DHA and DPA were incorporated into granulocytes in patients receiving n-3 FAs, but this was not associated with improved postoperative outcomes.
This record has no associated files available for download.
More information
e-pub ahead of print date: 26 November 2013
Published date: January 2014
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 361816
URI: http://eprints.soton.ac.uk/id/eprint/361816
PURE UUID: f863e975-eda3-4077-8a9e-300b714aa0df
Catalogue record
Date deposited: 04 Feb 2014 11:18
Last modified: 15 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
L.S. Sorensen
Author:
O. Thorlacius-Ussing
Author:
E.B. Schmidt
Author:
H.H. Rasmussen
Author:
S. Lundbye-Christensen
Author:
K. Lindorff-Larsen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics